Abstract:Evidence suggests that the glycogen synthase kinase 3 (GSK3)-dictated nuclear exclusion and degradation of Nrf2 is pivotal in switching off the self-protective antioxidant stress response after injury. Here, we examined the mechanisms underlying this regulation in glomerular disease. In primary podocytes, doxorubicin elicited cell death and actin cytoskeleton disorganization, concomitant with overactivation of GSK3 beta (the predominant GSK3 isoform expressed in glomerular podocytes) and minimal Nrf2 activation. SB216763, a highly selective small molecule inhibitor of GSK3, exerted a protective effect that depended on the potentiated Nrf2 antioxidant response, marked by increased Nrf2 expression and nuclear accumulation and augmented production of the Nrf2 target heme oxygenase-1. Ectopic expression of the kinase-dead mutant of GSK3 beta in cultured podocytes reinforced the doxorubicin-induced Nrf2 activation and prevented podocyte injury. Conversely, a constitutively active GSK3 beta mutant blunted the doxorubicin-induced Nrf2 response and exacerbated podocyte injury, which could be abolished by treatment with SB216763. In murine models of doxorubicin nephropathy or nephrotoxic serum nephritis, genetic targeting of GSK3 beta by doxycycline-inducible podocyte-specific knockout or pharmacologic targeting by SB216763 significantly attenuated albuminuria and ameliorated histologic signs of podocyte injury, including podocytopenia, loss of podocyte markers, podocyte de novo expression of desmin, and ultrastructural lesions of podocytopathy (such as foot process effacement). This beneficial outcome was likely attributable to an enhanced Nrf2 antioxidant response in glomerular podocytes because the selective Nrf2 antagonist trigonelline abolished the proteinuria-reducing and podocyte-protective effect. Collectively, our results suggest the GSK3 beta-regulated Nrf2 antioxidant response as a novel therapeutic target for protecting podocytes and treating proteinuric glomerulopathies.

Podocyte-Specific Deletion of Signal Transducer and Activator of Transcription 3 Attenuates Nephrotoxic Serum-Induced Glomerulonephritis

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Deletion Of Podocyte Stat3 Mitigates The Entire Spectrum Of Hiv-1-Associated Nephropathy

An Essential Role for Stat3 in Regulating Igg Immune Complex-Induced Pulmonary Inflammation

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.

Knockdown of Stat3 Activity in Vivo Prevents Diabetic Glomerulopathy

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

Serum and Glucocorticoid-Inducible Kinase 3/Nedd4-2 Signaling Pathway Participates in Podocyte Injury by Regulating the Stability of Nephrin

Fine-tuning of NFκB by Glycogen Synthase Kinase 3β Directs the Fate of Glomerular Podocytes Upon Injury.

SMAD3-dependent and -Independent Pathways in Glomerular Injury Associated with Experimental Glomerulonephritis

STAT1 aggravates kidney injury by NOD-like receptor (NLRP3) signaling in MRL-lpr mice

T cell–specific STAT3 deficiency abrogates lupus nephritis

Expression of suppressor of cytokine signaling 3 during the course of mouse nephritis

Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice

A novel role of angiopoietin-like-3 associated with podocyte injury

Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis

STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model

Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.

Podocyte Activation of Nlrp3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Renin‐angiotensin blockade ameliorates the progression of glomerular injury in podocyte‐specific Ctcf knockout mice